Lv1
60 积分 2023-07-24 加入
Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial
4小时前
待确认
Sequential immunotherapy: towards cures for autoimmunity
4个月前
已完结
Glofitamab As Monotherapy and in Combination with Obinutuzumab Induces High Complete Response Rates in Patients (pts) with Multiple Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
5个月前
已关闭
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
5个月前
已完结
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer
5个月前
已完结
Recent successes in heart failure treatment
6个月前
已完结
[Form deprivation myopia in C57BL/6 mice]
6个月前
已完结
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
6个月前
已完结
改良型新药非临床研究的一般考虑及需要关注的问题
1年前
已完结
皖公网安备34019202002308
